Health-related quality of life in glioma patients in China

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Cheng, Jin Xiang ^a   Liu, Bo lin ^a   Zhang, Xiang ^a   Lin, Wei ^a   Zhang, Yong qiang ^a   Liu, Wei ping ^a   Zhang, Jian Ning ^a   Lin, Hong ^a   Wang, Rui ^b   Yin, Hong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANOREXIA; ARTICLE; CANCER GRADING; CHILD; CHINA; COGNITIVE DEFECT; CONSTIPATION; DIARRHEA; DYSPNEA; EMOTIONAL DISORDER; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE CORE QUESTIONNAIRE; FATIGUE; FEMALE; FUNCTIONAL STATUS; GLIOMA; HEALTH STATUS; HUMAN; INSOMNIA; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NAUSEA; PAIN; PHYSICAL DISABILITY; PREOPERATIVE EVALUATION; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEX DIFFERENCE; SOCIAL DISABILITY; SYMPTOM; TUMOR LOCALIZATION; TUMOR RECURRENCE; VOMITING; ADOLESCENT; BRAIN TUMOR; HEALTH SURVEY; MIDDLE AGED; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GLIOMA; HEALTH STATUS INDICATORS; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 77953626321     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-305     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: a cancer journal for clinicians 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, Uhm JH. Central nervous system tumors. Mayo Clinic proceedings 2007, 82(10):1271-1286. 10.4065/82.10.1271, 17908533.
3. Wen PY, Kesari S. Malignant gliomas in adults. The New England journal of medicine 2008, 359(5):492-507. 10.1056/NEJMra0708126, 18669428.
4. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmstrom PO, Collette L, Pierart M, Mirimanoff R, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005, 366(9490):985-990. 10.1016/S0140-6736(05)67070-5, 16168780.
5. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006, 106(6):1358-1363. 10.1002/cncr.21733, 16470608.
6. Gustafsson M, Edvardsson T, Ahlstrom G. The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 2006, 14(12):1205-1212. 10.1007/s00520-006-0080-3, 16710652.
7. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica 2007, 114(2):97-109. 10.1007/s00401-007-0243-4, 1929165, 17618441.
8. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. Journal of the National Cancer Institute 1993, 85(9):704-710. 10.1093/jnci/85.9.704, 8478956.
9. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005, 57(3):495-504. discussion 495-504, 10.1227/01.NEU.0000170562.25335.C7, 16145528.
10. Asthagiri AR, Pouratian N, Sherman J, Ahmed G, Shaffrey ME. Advances in brain tumor surgery. Neurol Clin 2007, 25(4):975-1003. viii-ix, 10.1016/j.ncl.2007.07.006, 17964023.
11. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, et al. Radiotherapy for glioblastoma in the elderly. The New England journal of medicine 2007, 356(15):1527-1535. 10.1056/NEJMoa065901, 17429084.
12. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 2005, 352(10):987-996. 10.1056/NEJMoa043330, 15758009.
13. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 2009, 27(35):5874-5880. 10.1200/JCO.2009.23.6497, 19901110.
14. Pang BC, Wan WH, Lee CK, Khu KJ, Ng WH. The role of surgery in high-grade glioma--is surgical resection justified? A review of the current knowledge. Ann Acad Med Singapore 2007, 36(5):358-363.
15. Reijneveld JC, Sitskoorn MM, Klein M, Nuyen J, Taphoorn MJ. Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 2001, 56(5):618-623.
16. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993, 85(5):365-376. 10.1093/jnci/85.5.365, 8433390.
17. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 1996, 5(1):139-150. 10.1007/BF00435979, 8901377.
18. Zhao H, Kanda K. Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30). J Epidemiol 2004, 14(6):193-203. 10.2188/jea.14.193, 15617393.
19. Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-oncology 2000, 2(4):221-228. 10.1215/15228517-2-4-221, 1920595, 11265231.
20. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. Journal of neuro-oncology 1997, 34(3):263-278. 10.1023/A:1005790632126, 9258818.
21. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. The lancet oncology 2009, 10(9):865-871. 10.1016/S1470-2045(09)70200-1, 19695956.
22. Yu ES, Liu WT, Levy P, Zhang MY, Katzman R, Lung CT, Wong SC, Wang ZY, Qu GY. Cognitive impairment among elderly adults in Shanghai, China. J Gerontol 1989, 44(3):S97-106.
23. Karnofsky DA, Abelman WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948, 1:634-656.
24. Katzman R, Zhang MY, Ouang Ya Q, Wang ZY, Liu WT, Yu E, Wong SC, Salmon DP, Grant I. A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 1988, 41(10):971-978. 10.1016/0895-4356(88)90034-0, 3193141.
25. Fayers PM, Aaronson Groenvold M, Curran D, A B. The EORTC QLQ-C30 Scoring Manual (3rd Edition). the EORTC Quality of Life Group 2001, European Organisation for Research and Treatment of Cancer, Brussels.
26. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16(1):139-144.
27. Cheng JX, Zhang X, Liu BL. Health-related quality of life in patients with high-grade glioma. Neuro-oncology 2009, 11(1):41-50. 10.1215/15228517-2008-050, 2718958, 18628405.
28. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, Mason W, Mirimanoff RO, Baumert BG, Eisenhauer E, et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. The lancet oncology 2005, 6(12):937-944. 10.1016/S1470-2045(05)70432-0, 16321761.
29. Taphoorn MJ, van den Bent MJ, Mauer ME, Coens C, Delattre JY, Brandes AA, Sillevis Smitt PA, Bernsen HJ, Frenay M, Tijssen CC, et al. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 2007, 25(36):5723-5730. 10.1200/JCO.2007.12.7514, 18089866.
30. Brown PD, Jensen AW, Felten SJ, Ballman KV, Schaefer PL, Jaeckle KA, Cerhan JH, Buckner JC. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 2006, 24(34):5427-5433. 10.1200/JCO.2006.08.5605, 17135644.
31. Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 2001, 19(20):4037-4047.
32. Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002, 360(9343):1361-1368. 10.1016/S0140-6736(02)11398-5, 12423981.
33. Bosma I, Vos MJ, Heimans JJ, Taphoorn MJ, Aaronson NK, Postma TJ, van der Ploeg HM, Muller M, Vandertop WP, Slotman BJ, et al. The course of neurocognitive functioning in high-grade glioma patients. Neuro-oncology 2007, 9(1):53-62. 10.1215/15228517-2006-012, 1828106, 17018697.
34. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 2006, 21(3):194-199. 10.1016/j.eurpsy.2005.05.008, 16140507.
35. Salo J, Niemela A, Joukamaa M, Koivukangas J. Effect of brain tumour laterality on patients' perceived quality of life. Journal of neurology, neurosurgery, and psychiatry 2002, 72(3):373-377. 10.1136/jnnp.72.3.373, 1737761, 11861699.
36. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. Journal of the American Geriatrics Society 1992, 40(9):922-935.
37. Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Gupta L, Tang-Wai DF, Arusell RM, Clark MM, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. Journal of neuro-oncology 2006, 76(3):283-291. 10.1007/s11060-005-7020-9, 16163448.
38. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol 2003, 21(13):2519-2524. 10.1200/JCO.2003.04.172, 12829670.
39. Zhao H, Kanda K. Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Qual Life Res 2000, 9(2):129-137. 10.1023/A:1008981520920, 10983477.
40. Sneeuw KC, Aaronson NK, Osoba D, Muller MJ, Hsu MA, Yung WK, Brada M, Newlands ES. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Medical care 1997, 35(5):490-506. 10.1097/00005650-199705000-00006, 9140337.